Following a response to MAPK pathway inhibition, there is an increase in PD-L1 expression on tumor cells and a higher lymphocytic infiltration (CD8/CD4), as well as, a decrease in Treg infiltration and immunosuppressive cytokines (IL6, IL10, VEGF) [5, 35]. Here, CD274 is linked to neoplasm.